Bluejay Diagnostics (BJDX) Assets Average (2021 - 2026)

Bluejay Diagnostics has disclosed Assets Average across 6 years of filings, most recently posting $6.4 million for Q1 2026.

• Assets Average for Q1 2026 came in at $6.4 million, up 6.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.4 million (up 6.56% YoY), and the FY2025 annual result was $6.9 million, up 19.53% from the prior year.
• Assets Average came in at $6.4 million for Q1 2026 at Bluejay Diagnostics, up from $6.0 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $20.5 million in Q1 2022 to a low of $5.0 million in Q1 2024.
• The 5-year median for Assets Average is $8.0 million (2024), against an average of $9.9 million.
• Across the five-year window, Assets Average plunged 59.26% in 2024 and advanced 20.03% in 2025, its largest moves.
• Bluejay Diagnostics' Assets Average stood at $14.6 million in 2022, then plunged by 55.13% to $6.6 million in 2023, then increased by 14.45% to $7.5 million in 2024, then declined by 19.99% to $6.0 million in 2025, then advanced by 5.9% to $6.4 million in 2026.
• The last three Assets Average figures came in at $6.4 million (Q1 2026), $6.0 million (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.